Signals, Powered By EquityPandit
Dr Reddy’s Laboratories has obtained establishment inspection report(EIR) for a unit of its Srikakulam plant in Andhra Pradesh, from the US health regulator.
In a filing to BSE Dr Reddy’s said, it has received EIR from the United States Food and Drug Administration(USFDA), for its formulations manufacturing facility at Srikakulam unit II.
Further, the company did not disclose if any observation in the EIR, has been made by US health regulator.
